Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease

Gastroenterology - Tập 152 Số 7 - Trang 1679-1694.e3 - 2017

Oscar Chávez‐Talavera^1,2,3,4, Anne Tailleux^1,2,3,4, Philippe Lefèbvre^1,2,4, Bart Staels^1,2,3,4

¹CHU Lille F-59000 Lille France

²Inserm, U1011, F-59000 Lille, France

³Institut Pasteur de Lille, F-59000 Lille, France

⁴Univ. Lille, U1011 -EGID, F-59000 Lille, France

Tóm tắt

Từ khóa

Tài liệu tham khảo

Lefebvre, 2009, Role of bile acids and bile acid receptors in metabolic regulation, Physiol Rev, 89, 147, 10.1152/physrev.00010.2008

Vlahcevic, 1997, Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat, Gastroenterology, 113, 1949, 10.1016/S0016-5085(97)70015-5

Duane, 1999, 27-hydroxycholesterol: production rates in normal human subjects, J Lipid Res, 40, 1194, 10.1016/S0022-2275(20)33481-7

Takahashi, 2016, Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans, J Lipid Res, 57, 2130, 10.1194/jlr.M071183

Duez, 2008, Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha, Gastroenterology, 135, 689, 10.1053/j.gastro.2008.05.035

Han, 2015, Circadian control of bile acid synthesis by a KLF15-Fgf15 axis, Nat Commun, 6, 7231, 10.1038/ncomms8231

Goodwin, 2000, A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis, Mol Cell, 6, 517, 10.1016/S1097-2765(00)00051-4

Inagaki, 2005, Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis, Cell Metab, 2, 217, 10.1016/j.cmet.2005.09.001

Ridlon, 2016, Consequences of bile salt biotransformations by intestinal bacteria, Gut Microbes, 7, 22, 10.1080/19490976.2015.1127483

Ridlon, 2006, Bile salt biotransformations by human intestinal bacteria, J Lipid Res, 47, 241, 10.1194/jlr.R500013-JLR200

Steiner, 2012, Lipoprotein distribution and serum concentrations of 7α-hydroxy-4-cholesten-3-one and bile acids: effects of monogenic disturbances in high-density lipoprotein metabolism, Clin Sci, 122, 385, 10.1042/CS20110482

Devlin, 2015, A biosynthetic pathway for a prominent class of microbiota-derived bile acids, Nat Chem Biol, 11, 685, 10.1038/nchembio.1864

Devkota, 2012, Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice, Nature, 487, 104, 10.1038/nature11225

Joyce, 2014, Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut, Proc Natl Acad Sci U S A, 111, 7421, 10.1073/pnas.1323599111

Swann, 2011, Systemic gut microbial modulation of bile acid metabolism in host tissue compartments, Proc Natl Acad Sci U S A, 108, 4523, 10.1073/pnas.1006734107

Sayin, 2013, gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist, Cell Metab, 17, 225, 10.1016/j.cmet.2013.01.003

Degirolamo, 2014, Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice, Cell Rep, 7, 12, 10.1016/j.celrep.2014.02.032

Wahlström, 2017, Induction of FXR signaling in germ-free mice colonized with a human microbiota, J Lipid Res, 58, 412, 10.1194/jlr.M072819

Boursier, 2015, Implication of gut microbiota in nonalcoholic fatty liver disease, PLoS Pathog, 11, e1004559, 10.1371/journal.ppat.1004559

Haeusler, 2013, Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids, Diabetes, 62, 4184, 10.2337/db13-0639

Lake, 2013, Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease, Toxicol Appl Pharmacol, 268, 132, 10.1016/j.taap.2013.01.022

Prinz, 2015, Plasma bile acids show a positive correlation with body mass index and are negatively associated with cognitive restraint of eating in obese patients, Front Neurosci, 9, 199, 10.3389/fnins.2015.00199

Mouzaki, 2016, Bile acids and dysbiosis in non-alcoholic fatty liver disease, PLoS One, 11, e0151829, 10.1371/journal.pone.0151829

Vrieze, 2014, Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity, J Hepatol, 60, 824, 10.1016/j.jhep.2013.11.034

Jiang, 2015, Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease, J Clin Invest, 125, 386, 10.1172/JCI76738

Stadlbauer, 2015, Lactobacillus casei Shirota supplementation does not restore gut microbiota composition and gut barrier in metabolic syndrome: a randomized pilot study, PLoS One, 10, e0141399, 10.1371/journal.pone.0141399

Reijnders, 2016, Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans: a randomized double-blind placebo-controlled trial, Cell Metab, 24, 63, 10.1016/j.cmet.2016.06.016

Lackey, 2016, Regulation of metabolism by the innate immune system, Nat Rev Endocrinol, 12, 15, 10.1038/nrendo.2015.189

Li, 2006, Bile acids and cytokines inhibit the human cholesterol 7α-hydroxylase gene via the JNK/c-Jun pathway, Hepatology, 43, 1202, 10.1002/hep.21183

Ferslew, 2015, Altered bile acid metabolome in patients with nonalcoholic steatohepatitis, Dig Dis Sci, 60, 3318, 10.1007/s10620-015-3776-8

Aranha, 2008, Bile acid levels are increased in the liver of patients with steatohepatitis, Eur J Gastroenterol Hepatol, 20, 519, 10.1097/MEG.0b013e3282f4710a

Spinelli, 2016, Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans, Int J Obes, 40, 1260, 10.1038/ijo.2016.46

Jansen, 2011, Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery, Dig Dis Basel Switz, 29, 48, 10.1159/000324128

Pournaras, 2012, The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control, Endocrinology, 153, 3613, 10.1210/en.2011-2145

Dutia, 2015, Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes, Int J Obes, 39, 806, 10.1038/ijo.2015.1

Simonen, 2012, Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass, Obes Surg, 22, 1473, 10.1007/s11695-012-0673-5

Werling, 2013, Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery, Scand J Gastroenterol, 48, 1257, 10.3109/00365521.2013.833647

Steinert, 2013, Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial, Obesity, 21, E660, 10.1002/oby.20522

Kohli, 2013, Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids, J Clin Endocrinol Metab, 98, E708, 10.1210/jc.2012-3736

Ahmad, 2013, Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity, Int J Obes, 37, 1553, 10.1038/ijo.2013.38

Sachdev, 2016, FGF 19 and bile acids increase following roux-en-Y gastric bypass but not after medical management in patients with type 2 diabetes, Obes Surg, 26, 957, 10.1007/s11695-015-1834-0

Dirksen, 2013, Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass, Int J Obes, 37, 1452, 10.1038/ijo.2013.15

Gerhard, 2013, A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass, Diabetes Care, 36, 1859, 10.2337/dc12-2255

Haluzíková, 2013, Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects, Obesity, 21, 1335, 10.1002/oby.20208

Goncalves, 2015, Bile routing modification reproduces key features of gastric bypass in rat, Ann Surg, 262, 1006, 10.1097/SLA.0000000000001121

Bhutta, 2015, Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats, PLoS One, 10, e0122273, 10.1371/journal.pone.0122273

Liou, 2013, Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity, Sci Transl Med, 5, 178ra41, 10.1126/scitranslmed.3005687

Ryan, 2014, FXR is a molecular target for the effects of vertical sleeve gastrectomy, Nature, 509, 183, 10.1038/nature13135

Patti, 2009, Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism, Obesity, 17, 1671, 10.1038/oby.2009.102

Ding, 2016, Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice, Hepatology, 64, 760, 10.1002/hep.28689

McGavigan, 2017, TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice, Gut, 66, 226, 10.1136/gutjnl-2015-309871

Wang, 1999, Endogenous bile acids are ligands for the nuclear receptor FXR/BAR, Mol Cell, 3, 543, 10.1016/S1097-2765(00)80348-2

Makishima, 2002, Vitamin D receptor as an intestinal bile acid sensor, Science, 296, 1313, 10.1126/science.1070477

Staudinger, 2001, The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity, Proc Natl Acad Sci U S A, 98, 3369, 10.1073/pnas.051551698

Kawamata, 2003, A G protein-coupled receptor responsive to bile acids, J Biol Chem, 278, 9435, 10.1074/jbc.M209706200

Nagahashi, 2016, The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases, J Lipid Res, 57, 1636, 10.1194/jlr.R069286

Sheikh Abdul Kadir, 2010, Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes, PLoS One, 5, e9689, 10.1371/journal.pone.0009689

Han, 2009, Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes, Drug Metab Dispos Biol Fate Chem, 37, 469, 10.1124/dmd.108.025155

Moore, 2002, Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors, Mol Endocrinol, 16, 977, 10.1210/mend.16.5.0828

Lee, 2014, Nutrient-sensing nuclear receptors coordinate autophagy, Nature, 516, 112, 10.1038/nature13961

Seok, 2014, Transcriptional regulation of autophagy by an FXR-CREB axis, Nature, 516, 108, 10.1038/nature13949

Berrabah, 2014, Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR), Hepatology, 59, 2022, 10.1002/hep.26710

Kemper, 2009, FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states, Cell Metab, 10, 392, 10.1016/j.cmet.2009.09.009

Lien, 2014, Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk, J Clin Invest, 124, 1037, 10.1172/JCI68815

Gineste, 2008, Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity, Mol Endocrinol, 22, 2433, 10.1210/me.2008-0092

Hashiguchi, 2016, Phosphorylation of farnesoid X Receptor at serine 154 links ligand activation with degradation, Mol Endocrinol, 30, 1070, 10.1210/me.2016-1105

Kim, 2015, A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity, EMBO J, 34, 184, 10.15252/embj.201489527

Reimann, 2008, Glucose sensing in L cells: a primary cell study, Cell Metab, 8, 532, 10.1016/j.cmet.2008.11.002

Thomas, 2009, TGR5-mediated bile acid sensing controls glucose homeostasis, Cell Metab, 10, 167, 10.1016/j.cmet.2009.08.001

Nagahashi, 2015, Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression, Hepatology, 61, 1216, 10.1002/hep.27592

Cariou, 2006, The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice, J Biol Chem, 281, 11039, 10.1074/jbc.M510258200

Abdelkarim, 2010, The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways, J Biol Chem, 285, 36759, 10.1074/jbc.M110.166231

Watanabe, 2006, Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation, Nature, 439, 484, 10.1038/nature04330

Broeders, 2015, The bile acid chenodeoxycholic acid increases human brown adipose tissue activity, Cell Metab, 22, 418, 10.1016/j.cmet.2015.07.002

Parséus, 2017, Microbiota-induced obesity requires farnesoid X receptor, Gut, 66, 429, 10.1136/gutjnl-2015-310283

Rizzo, 2006, The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo, Mol Pharmacol, 70, 1164, 10.1124/mol.106.023820

Fu, 2004, Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes, Endocrinology, 145, 2594, 10.1210/en.2003-1671

Fang, 2015, Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance, Nat Med, 21, 159, 10.1038/nm.3760

Watanabe, 2004, Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c, J Clin Invest, 113, 1408, 10.1172/JCI21025

Bhatnagar, 2009, Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis, J Biol Chem, 284, 10023, 10.1074/jbc.M808818200

Hirokane, 2004, Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4, J Biol Chem, 279, 45685, 10.1074/jbc.M404255200

Kast, 2001, Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids, Mol Endocrinol, 15, 1720, 10.1210/mend.15.10.0712

Claudel, 2003, Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression, Gastroenterology, 125, 544, 10.1016/S0016-5085(03)00896-5

Sirvent, 2004, The farnesoid X receptor induces very low density lipoprotein receptor gene expression, FEBS Lett, 566, 173, 10.1016/j.febslet.2004.04.026

Chennamsetty, 2012, FGF19 signaling cascade suppresses APOA gene expression, Arterioscler Thromb Vasc Biol, 32, 1220, 10.1161/ATVBAHA.111.243055

Claudel, 2002, Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element, J Clin Invest, 109, 961, 10.1172/JCI0214505

Zhang, 2010, Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia, J Biol Chem, 285, 3035, 10.1074/jbc.M109.083899

Gautier, 2013, Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice, J Lipid Res, 54, 2195, 10.1194/jlr.M038141

Wang, 2006, Effects of chenodeoxycholic acid and deoxycholic acid on cholesterol absorption and metabolism in humans, Transl Res J Lab Clin Med, 148, 37, 10.1016/j.lab.2006.03.009

Neuschwander-Tetri, 2015, Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial, Lancet Lond Engl, 385, 956, 10.1016/S0140-6736(14)61933-4

Nilsson, 2007, Bile acids and lipoprotein metabolism: effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression, Biochem Biophys Res Commun, 357, 707, 10.1016/j.bbrc.2007.03.196

Xu, 2016, Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice, Hepatology, 64, 1072, 10.1002/hep.28712

Ferrell, 2016, Cholesterol 7α-hydroxylase-deficient mice are protected from high-fat/high-cholesterol diet-induced metabolic disorders, J Lipid Res, 57, 1144, 10.1194/jlr.M064709

de Boer, 2017, Intestinal farnesoid X receptor controls transintestinal cholesterol excretion in mice, Gastroenterology, 152, 1126, 10.1053/j.gastro.2016.12.037

1984, The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease, JAMA, 251, 351, 10.1001/jama.1984.03340270029025

Zweers, 2012, The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract, Hepatology, 55, 575, 10.1002/hep.24702

Picard, 2016, A genetic screen identifies hypothalamic Fgf15 as a regulator of glucagon secretion, Cell Rep, 17, 1795, 10.1016/j.celrep.2016.10.041

Dijk TH van, 2009, An increased flux through the glucose 6-phosphate pool in enterocytes delays glucose absorption in Fxr-/- mice, J Biol Chem, 284, 10315, 10.1074/jbc.M807317200

Duran-Sandoval, 2005, The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition, J Biol Chem, 280, 29971, 10.1074/jbc.M501931200

Caron, 2013, Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes, Mol Cell Biol, 33, 2202, 10.1128/MCB.01004-12

Kir, 2011, FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis, Science, 331, 1621, 10.1126/science.1198363

Katsuma, 2005, Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1, Biochem Biophys Res Commun, 329, 386, 10.1016/j.bbrc.2005.01.139

Brighton, 2015, Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors, Endocrinology, 156, 3961, 10.1210/en.2015-1321

Trabelsi, 2015, Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells, Nat Commun, 6, 7629, 10.1038/ncomms8629

Popescu, 2010, The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity, FEBS Lett, 584, 2845, 10.1016/j.febslet.2010.04.068

Kumar, 2012, Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells, Biochem Biophys Res Commun, 427, 600, 10.1016/j.bbrc.2012.09.104

Kumar, 2016, Activation of transmembrane bile acid receptor TGR5 modulates pancreatic islet α cells to promote glucose homeostasis, J Biol Chem, 291, 6626, 10.1074/jbc.M115.699504

Seyer, 2013, Hepatic glucose sensing is required to preserve β cell glucose competence, J Clin Invest, 123, 1662, 10.1172/JCI65538

Smushkin, 2013, The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes, Diabetes, 62, 1094, 10.2337/db12-0923

Li, 2013, Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity, Nat Commun, 4, 2384, 10.1038/ncomms3384

Jiang, 2015, Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction, Nat Commun, 6, 10166, 10.1038/ncomms10166

McGettigan, 2016, Sevelamer improves steatohepatitis, inhibits liver and intestinal farnesoid X receptor (FXR), and reverses innate immune dysregulation in a mouse model of non-alcoholic fatty liver disease, J Biol Chem, 291, 23058, 10.1074/jbc.M116.731042

Kaur, 2015, Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1, Diabetes, 64, 1168, 10.2337/db14-0716

Yamagata, 2004, Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1, J Biol Chem, 279, 23158, 10.1074/jbc.M314322200

Ma, 2006, Farnesoid X receptor is essential for normal glucose homeostasis, J Clin Invest, 116, 1102, 10.1172/JCI25604

Stayrook, 2005, Regulation of carbohydrate metabolism by the farnesoid X receptor, Endocrinology, 146, 984, 10.1210/en.2004-0965

Mudaliar, 2013, Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease, Gastroenterology, 145, 574, 10.1053/j.gastro.2013.05.042

Lewis, 2014, A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo, PLoS One, 9, e100883, 10.1371/journal.pone.0100883

Keitel, 2008, Expression and function of the bile acid receptor TGR5 in Kupffer cells, Biochem Biophys Res Commun, 372, 78, 10.1016/j.bbrc.2008.04.171

Ichikawa, 2012, Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway, Immunology, 136, 153, 10.1111/j.1365-2567.2012.03554.x

Guo, 2016, Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome, Immunity, 45, 802, 10.1016/j.immuni.2016.09.008

Wang, 2011, The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice, Hepatology, 54, 1421, 10.1002/hep.24525

Pols, 2011, TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading, Cell Metab, 14, 747, 10.1016/j.cmet.2011.11.006

Liu, 2016, Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis, J Lipid Res, 57, 1831, 10.1194/jlr.M069807

Gadaleta, 2011, Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease, Gut, 60, 463, 10.1136/gut.2010.212159

Vavassori, 2009, The bile acid receptor FXR is a modulator of intestinal innate immunity, J Immunol, 183, 6251, 10.4049/jimmunol.0803978

Inagaki, 2006, Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor, Proc Natl Acad Sci U S A, 103, 3920, 10.1073/pnas.0509592103

Schiöth, 2016, A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease, BMC Genomics, 17, 462, 10.1186/s12864-016-2814-z

Verbeke, 2016, FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis, Sci Rep, 6, 33453, 10.1038/srep33453

Fickert, 2009, Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts, Am J Pathol, 175, 2392, 10.2353/ajpath.2009.090114

Feaver, 2016, Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis, JCI Insight, 1, e90954, 10.1172/jci.insight.90954

Pencek, 2016, Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers, Diabetes Obes Metab, 18, 936, 10.1111/dom.12681

Camilleri, 2015, Therapeutic targeting of bile acids, Am J Physiol Gastrointest Liver Physiol, 309, G209, 10.1152/ajpgi.00121.2015

Schaap, 2014, Bile acid receptors as targets for drug development, Nat Rev Gastroenterol Hepatol, 11, 55, 10.1038/nrgastro.2013.151

Duan, 2015, Discovery of intestinal targeted TGR5 Agonists for the treatment of type 2 diabetes, J Med Chem, 58, 3315, 10.1021/jm500829b

Briere, 2015, Novel small molecule agonist of TGR5 possesses anti-diabetic effects but causes gallbladder filling in mice, PLoS One, 10, e0136873, 10.1371/journal.pone.0136873

Alemi, 2013, The TGR5 receptor mediates bile acid-induced itch and analgesia, J Clin Invest, 123, 1513, 10.1172/JCI64551

Ge, 2014, Fibroblast growth factor receptor 4 (FGFR4) deficiency improves insulin resistance and glucose metabolism under diet-induced obesity conditions, J Biol Chem, 289, 30470, 10.1074/jbc.M114.592022

Rao, 2016, Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice, Sci Transl Med, 8, 357ra122, 10.1126/scitranslmed.aaf4823

Beraza, 2011, Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis, Gut, 60, 387, 10.1136/gut.2010.223834

Trauner, 2015, Potential of nor-ursodeoxycholic acid in cholestatic and metabolic disorders, Dig Dis Basel Switz, 33, 433, 10.1159/000371904

Mueller, 2015, Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity, J Hepatol, 62, 1398, 10.1016/j.jhep.2014.12.034

Downes, 2003, A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR, Mol Cell, 11, 1079, 10.1016/S1097-2765(03)00104-7

Sonne, 2016, postprandial plasma concentrations of individual bile acids and FGF-19 in patients with type 2 diabetes, J Clin Endocrinol Metab, 101, 3002, 10.1210/jc.2016-1607

Haeusler, 2013, Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids, Diabetes, 62, 4184, 10.2337/db13-0639

Vincent, 2013, Higher circulating bile acid concentrations in obese patients with type 2 diabetes, Ann Clin Biochem, 50, 360, 10.1177/0004563212473450

Wewalka, 2014, Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin, J Clin Endocrinol Metab, 99, 1442, 10.1210/jc.2013-3367

Cariou, 2011, Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults, Nutr Metab, 8, 48, 10.1186/1743-7075-8-48

Ferslew, 2015, Altered bile acid metabolome in patients with nonalcoholic steatohepatitis, Dig Dis Sci, 60, 3318, 10.1007/s10620-015-3776-8

Patti, 2009, Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism, Obesity (Silver Spring), 17, 1671, 10.1038/oby.2009.102

Nakatani, 2009, Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery, Metabolism, 58, 1400, 10.1016/j.metabol.2009.05.006

Jansen, 2011, Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery, Dig Dis, 29, 48, 10.1159/000324128

Pournaras, 2012, The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control, Endocrinology, 153, 3613, 10.1210/en.2011-2145

Simonen, 2012, Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass, Obes Surg, 22, 1473, 10.1007/s11695-012-0673-5

Gerhard, 2013, A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass, Diabetes Care, 36, 1859, 10.2337/dc12-2255

Kohli, 2013, Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids, J Clin Endocrinol Metab, 98, E708, 10.1210/jc.2012-3736

Albaugh, 2015, Early increases in bile acids post roux-en-y gastric bypass are driven by insulin-sensitizing, secondary bile acids, J Clin Endocrinol Metab, 100, E1225, 10.1210/jc.2015-2467

Sachdev, 2016, FGF 19 and bile acids increase following roux-en-Y gastric bypass but not after medical management in patients with type 2 diabetes, Obes Surg, 26, 957, 10.1007/s11695-015-1834-0

Steinert, 2013, Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial, Obesity, 21, E660, 10.1002/oby.20522

Werling, 2013, Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery, Scand J Gastroenterol, 48, 1257, 10.3109/00365521.2013.833647

Dutia, 2015, Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes, Int J Obes, 39, 806, 10.1038/ijo.2015.1

Jørgensen, 2015, Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations, J Clin Endocrinol Metab, 100, E396, 10.1210/jc.2014-1658

Ahmad, 2013, Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity, Int J Obes, 37, 1553, 10.1038/ijo.2013.38

Dirksen, 2013, Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass, Int J Obes, 37, 1452, 10.1038/ijo.2013.15

Haluzíková, 2013, Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects, Obesity (Silver Spring), 21, 1335, 10.1002/oby.20208

Ferrannini, 2015, Increased bile acid synthesis and deconjugation after biliopancreatic diversion, Diabetes, 64, 3377, 10.2337/db15-0214

Lefebvre, 2009, Role of bile acids and bile acid receptors in metabolic regulation, Physiol Rev, 89, 147, 10.1152/physrev.00010.2008

Pircher, 2003, Farnesoid X receptor regulates bile acid-amino acid conjugation, J Biol Chem, 278, 27703, 10.1074/jbc.M302128200

Ananthanarayanan, 2001, Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor, J Biol Chem, 276, 28857, 10.1074/jbc.M011610200

Boyer, 2006, Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents, Am J Physiol Gastrointest Liver Physiol, 290, G1124, 10.1152/ajpgi.00539.2005